BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 11702083)

  • 1. The effects of FK506, a specific calcineurin inhibitor, on methamphetamine-induced behavioral change and its sensitization in rats.
    Tsukamoto T; Iyo M; Tani K; Sekine Y; Hashimoto K; Ohashi Y; Suzuki K; Iwata Y; Mori N
    Psychopharmacology (Berl); 2001 Nov; 158(2):107-13. PubMed ID: 11702083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotyped behavioral responses to an auditory stimulus in the course of repeated treatment with methamphetamine plus scopolamine and methamphetamine in rats.
    Yui K; Miura T; Sugiyama K; Ono M; Nagase M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Jun; 14(3):169-78. PubMed ID: 7941782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NG-nitro-L-arginine methyl ester attenuates the maintenance and expression of methamphetamine-induced behavioral sensitization and enhancement of striatal dopamine release.
    Inoue H; Arai I; Shibata S; Watanabe S
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1424-30. PubMed ID: 8667206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of methamphetamine-induced behavioral sensitization by repeated administration of a dopamine D1 receptor agonist.
    Shuto T; Kuroiwa M; Hamamura M; Yabuuchi K; Shimazoe T; Watanabe S; Nishi A; Yamamoto T
    Neuropharmacology; 2006 Jun; 50(8):991-7. PubMed ID: 16563442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunophilin ligand FK506 protects against methamphetamine-induced dopaminergic neurotoxicity in mouse striatum.
    Koike K; Hashimoto K; Fukami G; Okamura N; Zhang L; Ohgake S; Koizumi H; Matsuzawa D; Kawamura N; Shimizu E; Iyo M
    Neuropharmacology; 2005 Mar; 48(3):391-7. PubMed ID: 15721171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of antioxidant N-acetyl-L-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine.
    Fukami G; Hashimoto K; Koike K; Okamura N; Shimizu E; Iyo M
    Brain Res; 2004 Jul; 1016(1):90-5. PubMed ID: 15234256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein expression profile in the striatum of rats with methamphetamine-induced behavioral sensitization.
    Iwazaki T; McGregor IS; Matsumoto I
    Proteomics; 2007 Apr; 7(7):1131-9. PubMed ID: 17351886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Behavioral changes induced by repeated administration of mazindol, an anorexiant, in rats].
    Kawakami Y; Suemaru K; Kawasaki H; Gomita Y
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Aug; 16(4):139-43. PubMed ID: 8905803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic preexposure to methylphenidate cross-sensitizes methamphetamine in male Japanese quail.
    Rosine BJ; Levi Bolin B; Akins CK
    Behav Pharmacol; 2009 Jul; 20(4):352-5. PubMed ID: 19584711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein expression profile in the amygdala of rats with methamphetamine-induced behavioral sensitization.
    Iwazaki T; McGregor IS; Matsumoto I
    Neurosci Lett; 2008 Apr; 435(2):113-9. PubMed ID: 18346852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic benzylpiperazine (BZP) exposure produces behavioral sensitization and cross-sensitization to methamphetamine (MA).
    Brennan K; Johnstone A; Fitzmaurice P; Lea R; Schenk S
    Drug Alcohol Depend; 2007 May; 88(2-3):204-13. PubMed ID: 17125936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral sensitization to the discriminative stimulus effects of methamphetamine in rats.
    Suzuki T; Fukuoka Y; Mori T; Miyatake M; Narita M
    Eur J Pharmacol; 2004 Sep; 498(1-3):157-61. PubMed ID: 15363990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methamphetamine-induced locomotor activity and behavioral sensitization: are dopamine d3 receptors involved?
    Jones CD; Bartee JA; Leite-Browning ML; Blackshear MA
    Cell Mol Biol (Noisy-le-grand); 2007 May; 53(4):15-22. PubMed ID: 17531156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice.
    Ago Y; Nakamura S; Uda M; Kajii Y; Abe M; Baba A; Matsuda T
    Neuropharmacology; 2006 Sep; 51(4):914-22. PubMed ID: 16863654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ritanserin reverses repeated methamphetamine-induced behavioral and neurochemical sensitization in mice.
    Ago Y; Nakamura S; Kajita N; Uda M; Hashimoto H; Baba A; Matsuda T
    Synapse; 2007 Sep; 61(9):757-63. PubMed ID: 17568413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of calcineurin inhibition and protein kinase A activation on nucleus accumbens amphetamine-produced conditioned place preference in rats.
    Gerdjikov TV; Beninger RJ
    Eur J Neurosci; 2005 Aug; 22(3):697-705. PubMed ID: 16101751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated alcohol: behavioral sensitization and alcohol-heightened aggression in mice.
    Fish EW; DeBold JF; Miczek KA
    Psychopharmacology (Berl); 2002 Feb; 160(1):39-48. PubMed ID: 11862372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methamphetamine-induced hyperactivity and behavioral sensitization in PACAP deficient mice.
    Fujii H; Ishihama T; Ago Y; Shintani N; Kakuda M; Hashimoto H; Baba A; Matsuda T
    Peptides; 2007 Sep; 28(9):1674-9. PubMed ID: 17658665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single social defeat induces short-lasting behavioral sensitization to amphetamine.
    de Jong JG; Wasilewski M; van der Vegt BJ; Buwalda B; Koolhaas JM
    Physiol Behav; 2005 Jan; 83(5):805-11. PubMed ID: 15639166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anthraquinone derivative emodin attenuates methamphetamine-induced hyperlocomotion and startle response in rats.
    Mizuno M; Kawamura H; Ishizuka Y; Sotoyama H; Nawa H
    Pharmacol Biochem Behav; 2010 Dec; 97(2):392-8. PubMed ID: 20863847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.